<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We investigated the hypothesis that <z:chebi fb="0" ids="35475">nonsteroidal antiinflammatory agents</z:chebi> can influence the abnormal <z:chebi fb="0" ids="26347">prostanoid</z:chebi> production associated with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We specifically assessed whether aspirin or <z:chebi fb="0" ids="49662">indomethacin</z:chebi> could eliminate the increased placental <z:chebi fb="0" ids="26995">thromboxane</z:chebi> production previously observed with immunoglobulin G fractions from patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> without adversely affecting prostacyclin production </plain></SENT>
<SENT sid="2" pm="."><plain>STUDY DESIGN: Immunoglobulin G fractions were prepared from the plasma of eight nonpregnant patients with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome and demonstrable <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Samples from each patient were then placed in incubation wells containing explants from <z:mpath ids='MPATH_458'>normal</z:mpath> term pregnancies and 10(-4) mol/L aspirin, 10(-7) mol/L <z:chebi fb="0" ids="49662">indomethacin</z:chebi>, or no added drug </plain></SENT>
<SENT sid="4" pm="."><plain>Aliquots were removed at intervals up to 48 hours of incubation and assessed for placental prostacyclin and <z:chebi fb="0" ids="26995">thromboxane</z:chebi> production by radioimmunoassay of the stable metabolites <z:chebi fb="0" ids="28852">prostaglandin F1 alpha</z:chebi> and <z:chebi fb="0" ids="28728">thromboxane B2</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The addition of aspirin to wells containing immunoglobulin G from patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was associated with a significant decrease in <z:chebi fb="0" ids="26995">thromboxane</z:chebi> production compared with wells without added drug, but prostacyclin production was unaffected </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, the addition of <z:chebi fb="0" ids="49662">indomethacin</z:chebi> also decreased <z:chebi fb="0" ids="26995">thromboxane</z:chebi> production significantly, but prostacyclin production was also diminished, so the ratio of <z:chebi fb="0" ids="26995">thromboxane</z:chebi> to prostacyclin was unaffected </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: These results support a role for the use of aspirin for <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo>-related pregnancy loss through a mechanism similar to that postulated for <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e>, namely, selective inhibition of <z:chebi fb="0" ids="26995">thromboxane</z:chebi> production </plain></SENT>
</text></document>